# K142441: cryoICE croablation probe

- Pathway: 510(k) (Special)
- Applicant: AtriCure, Inc.
- Decided: Oct 29, 2014 after 57 days
- Product code: GEH (Unit, Cryosurgical, Accessories)
- Device class: 2
- Regulation: 21 CFR 878.4350
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K942299 (1995). 45 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 47 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K082074: Atricure CRYO1 Cryo-Ablation Probe, AtriCure, Inc. (2009) Summary page 4.

## Most influential descendants
- K180137: AtriCure cryoICE cryo-ablation probe (CRYO3), AtriCure cryoICE cryoFORM cryo-ablation probe (CRYOF) (2018), 0 descendants of its own

## Indications for use
AtriCure’s cryoICE cryo-ablation probe is a sterile, single use device intended for use in the cryosurgical treatment of cardiac arrhythmias. The probe freezes target tissues, creating an inflammatory response (cryonecrosis) that blocks the electrical conduction pathway.

Source page: https://510kreport.com/device/K142441
Methodology: https://510kreport.com/methodology